U.S. stocks edged lower; Q2 GDP rose more than expected, Nvidia disappoints
SANTA CLARA - Agilent Technologies Inc. (NYSE:A) shares gained 3% after the analytical and clinical laboratory technologies provider reported stronger-than-expected third-quarter revenue and raised its full-year outlook, driven by continued momentum across all business segments.
The company reported third-quarter revenue of $1.74 billion, exceeding analyst estimates of $1.67 billion and representing 10.1% growth YoY. Adjusted earnings per share came in at $1.37, in line with analyst expectations.
The revenue performance marked Agilent’s fifth consecutive quarter of sequential core-revenue acceleration. Shares rose 3% following the results, reflecting investor approval of the company’s strong revenue performance.
"Our third-quarter performance is a testament to the success of our Ignite Transformation and our laser-like focus on profitable growth and operational excellence," said Agilent President and CEO Padraig McDonnell. "All three of our business groups grew, along with all regions and our two largest markets."
The Life Sciences and Diagnostics Markets Group led growth with a 14% revenue increase to $670 million. The Agilent CrossLab Group saw revenue rise 8% to $744 million, while the Applied Markets Group posted a 7% increase to $324 million.
Looking ahead, Agilent raised its full-year revenue outlook to between $6.91 billion and $6.93 billion, representing growth of 6.2% to 6.5%. The company expects fourth-quarter revenue of $1.822 billion to $1.842 billion, well above the consensus estimate of $1.75 billion, with adjusted EPS projected at $1.57 to $1.60.
The strong performance comes despite what the company described as "a full quarter of the dynamic tariff environment," demonstrating Agilent’s ability to navigate challenging market conditions while maintaining growth momentum.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.